State of Wisconsin Investment Board’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,437
| Closed | -$2.8M | – | 2616 |
|
|
2023
Q2 | $2.8M | Buy |
27,437
+3,206
| +13% | +$303K | 0.01% | 1199 |
|
|
2023
Q1 | $2.2M | Sell |
24,231
-2,716
| -10% | -$159K | 0.01% | 1269 |
|
|
2022
Q4 | $1.02M | Sell |
26,947
-31,552
| -54% | -$1.09M | ﹤0.01% | 1492 |
|
|
2022
Q3 | $1.47M | Buy |
58,499
+31,247
| +115% | +$866K | ﹤0.01% | 1420 |
|
|
2022
Q2 | $828K | Sell |
27,252
-8,548
| -24% | -$255K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $1.17M | Hold |
35,800
| – | – | ﹤0.01% | 1607 |
|
|
2021
Q4 | $944K | Hold |
35,800
| – | – | ﹤0.01% | 1466 |
|
|
2021
Q3 | $3.6M | Buy |
35,800
+1,100
| +3% | +$129K | 0.01% | 1139 |
|
|
2021
Q2 | $4.91M | Buy |
34,700
+31,339
| +932% | +$3.54M | 0.01% | 1056 |
|
|
2021
Q1 | $335K | Buy |
3,361
+271
| +9% | +$31.6K | ﹤0.01% | 1772 |
|
|
2020
Q4 | $382K | Sell |
3,090
-130
| -4% | -$17.1K | ﹤0.01% | 1612 |
|
|
2020
Q3 | $314K | Sell |
3,220
-290
| -8% | -$36.2K | ﹤0.01% | 1818 |
|
|
2020
Q2 | $548K | Sell |
3,510
-31,490
| -90% | -$4.79M | ﹤0.01% | 1403 |
|
|
2020
Q1 | $5.05M | Buy |
35,000
+4,900
| +16% | +$946K | 0.02% | 779 |
|
|
2019
Q4 | $6.15M | Hold |
30,100
| – | – | 0.02% | 873 |
|
|
2019
Q3 | $2.42M | Buy |
30,100
+2,700
| +10% | +$229K | 0.01% | 990 |
|
|
2019
Q2 | $2.58M | Buy |
27,400
+2,800
| +11% | +$242K | 0.01% | 976 |
|
|
2019
Q1 | $2.1M | Buy |
24,600
+5,600
| +29% | +$465K | 0.01% | 996 |
|
|
2018
Q4 | $1.07M | Buy |
19,000
+2,800
| +17% | +$171K | ﹤0.01% | 1112 |
|
|
2018
Q3 | $1.32M | Hold |
16,200
| – | – | ﹤0.01% | 1118 |
|
|
2018
Q2 | $567K | Buy |
+16,200
| New | +$493K | ﹤0.01% | 1331 |
|
Other funds holding RETA
State of Wisconsin Investment Board's RETA Position: Q3 2023 in Review
State of Wisconsin Investment Board sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 27,437 shares — an estimated $2.8M sold.
State of Wisconsin Investment Board first reported a position in RETA in Q2 2018 and held it in 21 quarters. The position peaked at $6.15M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- State of Wisconsin Investment Board reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- State of Wisconsin Investment Board sold 27,437 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.8M.
- State of Wisconsin Investment Board first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2018 and held it in 21 quarters.
- State of Wisconsin Investment Board's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $6.15M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.